Trials / Recruiting
RecruitingNCT07195175
Study of MAR002 in Healthy Men
First in Human, Randomized, Blinded, Placebo-Controlled Single Ascending Dose and Multiple Dose Study of MAR002 in Healthy Men
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Marea Therapeutics · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MAR002 | subcutaneous injection |
| DRUG | Placebo | Subcutaneous injection |
Timeline
- Start date
- 2025-08-11
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2025-09-26
- Last updated
- 2026-01-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07195175. Inclusion in this directory is not an endorsement.